相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel approach to calculating the kinetically derived maximum dose
Lyle D. Burgoon et al.
ARCHIVES OF TOXICOLOGY (2022)
Actions of Alcohol in Brain: Genetics, Metabolomics, GABA Receptors, Proteomics and Glutamate Transporter GLAST/EAAT1
Mohammed Abul Kashem et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures
Melvin E. Andersen et al.
ENVIRONMENTAL RESEARCH (2021)
Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling
Gaelle Magliocco et al.
PEDIATRIC RESEARCH (2020)
Evaluation of the Inherent Toxicity Concept in Environmental Toxicology and Risk Assessment
L. S. McCarty et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2020)
Use of the kinetically-derived maximum dose concept in selection of top doses for toxicity studies hampers proper hazard assessment and risk management
Minne B. Heringa et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Regulating human safety: How dose selection in toxicity studies impacts human health hazard assessment and subsequent risk management options
Marjolijn Woutersen et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
The Relatiorwhip Between Internal and External Dose: Some General Results Bas Id on a Generic Compartmental Model
Wout Slob et al.
TOXICOLOGICAL SCIENCES (2020)
A Kinetic Analysis of DNA-Deoxy Guanine Adducts in the Nasal Epithelium Produced by Inhaled Formaldehyde in Rats-Assessing Contributions to Adduct Production From Both Endogenous and Exogenous Sources of Formaldehyde
Jerry L. Campbell et al.
TOXICOLOGICAL SCIENCES (2020)
Use of the kinetically-derived maximum dose: Opportunities for delivering 3Rs benefits
Fiona Sewell et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Rebuttal to the letters to the editors by Terry et al. and Sewell et al. regarding Heringa et al. (2020)
Minne B. Heringa et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Rebuttal to the letter to the editors regarding Heringa et al. (2020)
Minne B. Heringa et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Letter to the editors regarding Heringa et al. (2020)
Carr J. Smith et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Letter to the editor regarding Heringa et al. (2020) paper entitled Use of the Kinetically-derived Maximum Dose concept in selection of top doses for toxicity studies hampers proper hazard assessment and risk management
Claire Terry et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems
Patrick M. Glassman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Distinguishing between endocrine disruption and non-specific effects on endocrine systems
M. Sue Marty et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Combining transcriptomics and PBPK modeling indicates a primary role of hypoxia and altered circadian signaling in dichloromethane carcinogenicity in mouse lung and liver
Melvin E. Andersen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Refinement of the oral exposure description in the cyclic siloxane PBPK model for rats and humans: Implications for exposure assessment
Jerry L. Campbell et al.
TOXICOLOGY LETTERS (2017)
Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications
Angela P. Cadavid
FRONTIERS IN IMMUNOLOGY (2017)
Ethanol elimination rates at low concentrations based on two consecutive blood samples
Gudrun Hoiseth et al.
FORENSIC SCIENCE INTERNATIONAL (2016)
Development of an integrated multi-species and multi-dose route PBPK model for volatile methyl siloxanes-D4 and D5
Tami S. McMullin et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Modernizing problem formulation for risk assessment necessitates articulation of mode of action
Christopher J. Borgert et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2015)
Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations
Floris A. Groothuis et al.
TOXICOLOGY (2015)
The role of pharmacokinetic studies in drug discovery: where are we now, how did we get here and where are we going?
Peter J. H. Webborn
FUTURE MEDICINAL CHEMISTRY (2014)
Development of Pbpk Models for Pfoa and Pfos for Human Pregnancy and Lactation Life Stages
Anne E. Loccisano et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2013)
Life-Stage-, Sex-, and Dose-Dependent Dietary Toxicokinetics and Relationship to Toxicity of 2,4-Dichlorophenoxyacetic Acid (2,4-D) in Rats: Implications for Toxicity Test Dose Selection, Design, and Interpretation
Shakil A. Saghir et al.
TOXICOLOGICAL SCIENCES (2013)
Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework
Russell S. Thomas et al.
TOXICOLOGICAL SCIENCES (2013)
Application of a Multi-Route Physiologically Based Pharmacokinetic Model for Manganese to Evaluate Dose-Dependent Neurological Effects in Monkeys
Jeffry D. Schroeter et al.
TOXICOLOGICAL SCIENCES (2012)
Update on a Pharmacokinetic-Centric Alternative Tier II Programfor MMT- Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment
Michael D. Taylor et al.
JOURNAL OF TOXICOLOGY (2012)
Analysis of Manganese Tracer Kinetics and Target Tissue Dosimetry in Monkeys and Humans with Multi-Route Physiologically Based Pharmacokinetic Models
Jeffry D. Schroeter et al.
TOXICOLOGICAL SCIENCES (2011)
Physiologically Based Pharmacokinetic Modeling of Fetal and Neonatal Manganese Exposure in Humans: Describing Manganese Homeostasis during Development
Miyoung Yoon et al.
TOXICOLOGICAL SCIENCES (2011)
Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework
Alan Wayne Jones
FORENSIC SCIENCE INTERNATIONAL (2010)
BIOKINETIC MODELING AND IN VITRO-IN VIVO EXTRAPOLATIONS
Bas J. Blaauboer
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2010)
Formaldehyde: Integrating Dosimetry, Cytotoxicity, and Genomics to Understand Dose-Dependent Transitions for an Endogenous Compound
Melvin E. Andersen et al.
TOXICOLOGICAL SCIENCES (2010)
Salicylate Intoxication: A Clinical Review
Brian L. Pearlman et al.
POSTGRADUATE MEDICINE (2009)
Quantitative interpretation of human biomonitoring data
Harvey J. Clewell et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
Anetta Undas et al.
BLOOD (2007)
Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment
Angel Lanas et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys - Probing the determinants of long plasma half-lives
Melvin E. Andersen et al.
TOXICOLOGY (2006)
Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
DW Gaylor
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2005)
Dose-dependent transitions in mechanisms of toxicity
W Slikker et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Dose-dependent transitions in mechanisms of toxicity: case studies
W Slikker et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Chemical mixture toxicology: from descriptive to mechanistic, and going on to in silico toxicology
RSH Yang et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2004)
Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry
HJ Clewell et al.
TOXICOLOGICAL SCIENCES (2004)
Characterization of the pharmacokinetics of gasoline using PBPK modeling with a complex mixtures chemical lumping approach
JE Dennison et al.
INHALATION TOXICOLOGY (2003)
A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures
S Haddad et al.
TOXICOLOGICAL SCIENCES (2001)
分享论文
